AnnoPro-tissue test:It is applicable for fresh tissue samples (including fresh pleural effusion samples), puncture tissue, paraffin section tissue, etc., NGS technology is used for gene detection. Expert Consensus in Field of Lung Cancer 1) High-throughput sequencing has good sensitivity, specificit...
This may be a relief. However, there is also the frustrating fact that even if a woman has a negative genetic test, she is still at higher risk for breast cancer than the general population due to the risk factor of having multiple family members with breast cancer. Another possibility with...
ARTICLE Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: Comparing breast and ovarian cancers with colon cancers Robert Cook-Deegan, MD1, Christopher DeRienzo, MD, MPP2, Julia Carbone, LLB, LLM3, Subhashini Chandrasekharan, PhD1, ...
test can be used to screen for mutations related to heterogeneous malignant tumors, and may be able to find disease-related genetic mutations. NGS uses sequencing of multiple sites instead of single site detection, which can make better use of samples and reduce sampling times. For lung cancer ...
This cohort study examines whether breast cancer–specific mortality for women with hormone-dependent breast cancer and the prognostic accuracy of a
U.S. regulators have approved a first-of-a-kind test that looks for mutations in hundreds of cancer genes at once, giving a more complete picture of what's driving a patient's tumor and aiding efforts to match treatments to those flaws.
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.
Reports on the difficulties in testing for the hereditary BRCA1 breast cancer gene. Discovery of different disease-causing mutations along the length of BRCA1; Failure of tests on women with cancer; Randomness of ...
A new generation of personalised cancer treatments will move a step closer when the world’s first nationwide genetic testing programme for cancer patients goes into action in the UK next month, with support from the public, private and charitable sectors. Cancer Research UKis leading the new...
This breakthrough discovery directed researches to examine role of miRNA in cancer since miRNAs are involved in the development, cell differentiation, and ... Y Tutar - 《Current Pharmaceutical Biotechnology》 被引量: 93发表: 2014年 High prevalence of mutations in the dihydrofolate reductase gene of...